2023 Form 5500 filing — Inovio Pharmaceuticals, Inc. 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241010091140NAL0033670832001) for Inovio Pharmaceuticals, Inc. 401(K) Plan, reported by Inovio Pharmaceuticals, Inc. under EIN 33-0969592 and plan number 001. It reports 377 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20241010091140NAL0033670832001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Inovio Pharmaceuticals, Inc.
- EIN
- 33-0969592
- Plan number
- 001
- Location
- San Diego, CA
- Participants
- 377
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $37,333,693
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $37,333,693
- Employer contributions
- $1,358,996
- Participant contributions
- $2,844,717
- Total income / additions
- $10,362,331
- Benefits paid
- $4,337,944
- Administrative expenses
- $76,404
- Total expenses
- $4,414,348
- Net increase / (decrease)
- $5,947,983
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Lpl Financial Corporation | NONE | $69,108 | not reported in the loaded dataset |
| Minnesota Life Insurance Company | NONE | $7,296 | $0 |